Open access
Aug 2026
Identification and validation of LOXL2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma through multi-omics and functional analysis
This study aimed to identify novel prognostic biomarkers for lung adenocarcinoma (LUAD) and elucidate their roles in tumor progression through the application of a multi-omics approach. Differentially expressed genes related to LUAD were identified using genome-wide and transcriptomics data, along with single-cell RNA...
Tie-Gang Cao, G. Qiao, Ming-Dong Ma et al.
· Discover Oncology · 0 citations